| Vitamin D Research Studies | Lifetime | 36 | US 20 | 99.50 |
| Lipoproteins and Cardiovascular Health | Lifetime | 107 | US 61 | 99.39 |
| Cardiac Health and Mental Health | Lifetime | 94 | US 55 | 98.98 |
| Cardiovascular Health and Risk Factors | Lifetime | 51 | US 36 | 99.11 |
| Cardiovascular Disease and Adiposity | Lifetime | 179 | US 103 | 99.01 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 548 | US 258 | 98.66 |
| Sex and Gender in Healthcare | Lifetime | 23 | US 18 | 97.38 |
| Cardiovascular Issues in Pregnancy | Lifetime | 196 | US 90 | 98.15 |
| Acute Myocardial Infarction Research | Lifetime | 412 | US 195 | 98.71 |
| Cardiac Imaging and Diagnostics | Lifetime | 858 | US 426 | 98.73 |
| Bone health and osteoporosis research | Lifetime | 331 | US 140 | 98.33 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 487 | US 210 | 98.40 |
| Vitamin C and Antioxidants Research | Lifetime | 178 | US 79 | 97.42 |
| COVID-19 and healthcare impacts | Lifetime | 496 | US 184 | 94.51 |
| Nutritional Studies and Diet | Lifetime | 653 | US 259 | 97.92 |
| Long-Term Effects of COVID-19 | Lifetime | 906 | US 204 | 94.50 |
| Heart rate and cardiovascular health | Lifetime | 241 | US 82 | 86.31 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 887 | US 221 | 85.95 |
| Biomarkers in Disease Mechanisms | Lifetime | 736 | US 189 | 82.43 |
| Menopause: Health Impacts and Treatments | Lifetime | 965 | US 483 | 86.56 |
| Aortic Thrombus and Embolism | Lifetime | 333 | US 142 | 80.20 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 743 | US 235 | 77.47 |
| Cardiac Health and Mental Health | 2021-2025 | 4 | US 2 | 99.49 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 6 | US 4 | 99.40 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 3 | US 3 | 99.57 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 8 | US 4 | 99.11 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 15 | US 7 | 99.62 |
| Sex and Gender in Healthcare | 2021-2025 | 2 | US 1 | 98.53 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 119 | US 36 | 98.37 |
| Vitamin D Research Studies | 2021-2025 | 21 | US 8 | 97.84 |
| Health disparities and outcomes | 2021-2025 | 100 | US 36 | 97.79 |
| Acute Myocardial Infarction Research | 2021-2025 | 100 | US 35 | 98.19 |
| Diet and metabolism studies | 2021-2025 | 206 | US 62 | 97.56 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 95 | US 32 | 97.07 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 287 | US 120 | 97.86 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 321 | US 103 | 97.70 |
| Diabetes Treatment and Management | 2021-2025 | 212 | US 81 | 97.63 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 181 | US 75 | 96.54 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 75 | US 19 | 95.15 |
| Pregnancy and preeclampsia studies | 2021-2025 | 226 | US 68 | 96.22 |
| COVID-19 and healthcare impacts | 2021-2025 | 393 | US 137 | 93.84 |
| Heart Failure Treatment and Management | 2021-2025 | 444 | US 151 | 94.67 |
| Hormonal and reproductive studies | 2021-2025 | 200 | US 52 | 91.89 |
| Pharmaceutical Economics and Policy | 2021-2025 | 187 | US 73 | 89.67 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 326 | US 61 | 87.19 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 74 | US 20 | 85.14 |
| Vitamin C and Antioxidants Research | 2021-2025 | 112 | US 26 | 85.25 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 524 | US 143 | 87.25 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 643 | US 123 | 87.04 |
| Gestational Diabetes Research and Management | 2021-2025 | 754 | US 178 | 85.73 |
| Cardiovascular Effects of Exercise | 2021-2025 | 711 | US 193 | 85.28 |
| Maternal and fetal healthcare | 2021-2025 | 554 | US 190 | 86.30 |
| Pharmacology and Obesity Treatment | 2021-2025 | 212 | US 101 | 84.56 |
| Hormonal Regulation and Hypertension | 2021-2025 | 677 | US 143 | 83.64 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 365 | US 111 | 80.12 |
| Diversity and Career in Medicine | 2021-2025 | 946 | US 743 | 80.03 |
| Bone health and osteoporosis research | 2021-2025 | 776 | US 135 | 80.33 |
| Health and Medical Research Impacts | 2021-2025 | 350 | US 203 | 76.93 |
| Healthcare cost, quality, practices | 2021-2025 | 583 | US 241 | 76.97 |
| Lipid metabolism and disorders | 2021-2025 | 349 | US 84 | 76.31 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 157 | US 25 | 75.80 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 275 | US 102 | 74.43 |
| Medication Adherence and Compliance | 2021-2025 | 767 | US 257 | 72.21 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 744 | US 261 | 52.26 |